Boston Scientific earnings: CRM slump continues as BSX swings to a loss in Q2, lowers guidance for 2012


Boston Scientific (NYSE:BSX) swung to a $3.4 billion loss, lowered its year-end guidance and saw its bread and butter businesses drop by double-digit percentage points during a tough 2nd quarter for the medical device company.

The Natick, Mass.-based medical device maker took a massive $3.43 billion non-cash impairment of goodwill to its bottom line, swinging the company to a $3.40 billion net loss on $1.82 billion in sales for the 3-month period ended June 30, compared to a $146 million profit on $1.98 in sales during the same period last year. Excluding those charges the company said it would have posted a $239 million profit for the quarter.

Sign up to get our free newsletters delivered right to your inbox

Total sales during the quarter were off about 7.4%, compared to the same period last year, primarily due to soft sales in the company’s ICD business, which was off 16% from the same period last year. BSX’s CRM business was off 10% from the same period last year. And, surprisingly, Boston’s drug-eluting stent business was off 20% worldwide.

"No doubt, this was a tough quarter," BSX CEO Hank Kucheman told investors during the company’s conference call, blaming the soft sales on a myriad of factors including a weakened global economy.

In particular, he said that the CRM market has not hit the bottom yet, confirming what St. Jude Medical (NYSE:STJ) CEO Daniel Starks suggested last week during the company’s earnings report.

"We believe that the worldwide CRM market will continue to be sluggish in 2012, declining about 3 to 5 % on a constant currency basis" Kucheman told investors". "We have not concluded that we’ve seen the bottom at the CRM market at this point."

To reflect the seriousness of the slump, BSX took the massive non-cash hit to its bottom line due to “slightly lower projected long-term growth rates due to macroeconomic factors and its performance in the European market.”

This is the second time the company has adjusted its goodwill in the past 15 months. In April, 2011 the company recorded a $723 million charge related to the weakening U.S. CRM market.

The company also lowered 2012 sales guidance to $7.2 to $7.4 billion in 2012, down from earlier estimates of $7.35 to $7.65 billion and the The Street’s estimates of $7.46 billion.

Shares of BSX were down 3% on Wall Street in early trading.

RSS From Medical Design & Outsourcing

  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]
  • MasterControl’s CEO talks EQMS software and new partnerships
    MasterControl offers a quality and compliance software that helps device companies speed time to market and improve their bottom lines. Under Jon’s leadership, the company has blossomed into a market leader and has a unique corporate culture that fosters growth, excellence and quality. In this podcast, MasterControl’s CEO, Jon Beckstrand, will discuss electronic quality management […]
  • BIT Group launches white label IVD solutions
    BIT Group has launched a product line of customizable IVD white label instruments. During recent years, BIT has invested capital and resources developing customizable, ready-to-use IVD systems to address a growing demand. “The IVD market is challenging for our clients,” said Marius Balger, CEO at BIT. “OEM’s must adhere to a growing number of evolving IVD […]
  • Toshiba expands line-up of ARM Cortex-M-based microcontrollers
    Toshiba announced that it has enhanced its current “TX Family” of ARM core-based microcontrollers and started to develop three series of microcontrollers, “TXZ0 series,” “TXZ3 series” and “TXZ4 series,” as part of the “TXZTM Family.” The TXZTM Family is a new collection of flash microcontrollers that support low-power consumption and high-speed operation for IoT and M2M […]
  • Parker Hannifin consolidates, layoffs ahead
    Parker Hannifin plans to consolidate a number of internal divisions, close 2 facilities and expand its Mexican operations, according to an internally distributed letter from Andy Ross, Parker’s engineered materials group president. The company has confirmed the letter was authentic, but has not disclosed how many employees will be affected by the new plans or […]
  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]
  • TSO3 begins shipment of STERIZONE VP4 Sterilizers to U.S.
    TSO3, a developer in sterilization technology for medical devices in healthcare settings, announced that the company has received purchase orders for multiple devices from the U.S. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and TSO3. “Finally,” said R.M. Rumble, president and CEO of TSO3. “Our Vision is […]
  • Turkish medical company is seeking reseller and OEM partners in the U.S.
    UZUMCU Medical Equipment, one of Turkey’s first and largest manufacturers of medical devices, is seeking reseller and OEM partners in the U.S. The company has an array of FDA-certified OR tables, surgical lights, surgical suction units, electro devices and other medical equipment. “We want to bring our experience with distributors throughout Europe and the Middle […]
  • QImaging introduces new CCD cameras for microscopy with modern software to streamline image capture
    QImaging, a manufacturer of scientific cameras for life science and OEM applications, introduces a new series of Retiga CCD cameras, accompanied by QImaging’s new acquisition software to deliver high-performance tools for microscopy and imaging to researchers at an affordable price. The new QImaging Retiga R1, Retiga R3 and Retiga R6 cameras offer valuable technical features […]

Leave a Reply